Tvardi Therapeutics, Inc.
TVRD
$28.34
$1.706.36%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | |||
|---|---|---|---|---|---|
| Net Income | 159.74% | -127.96% | -192.05% | ||
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | -12,955.32% | 5,716.84% | 2,014.29% | ||
| Change in Net Operating Assets | -51.52% | -6,554.55% | 480.13% | ||
| Cash from Operations | -119.04% | -85.81% | 15.93% | ||
| Capital Expenditure | -- | -- | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | -- | ||
| Cash from Investing | -- | -- | -- | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -- | -40.00% | -- | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | -- | -32,160.00% | -- | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 443.75% | -388.14% | 485.74% | ||